Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Critical appraisal of international guidelines for the management of Helicobacter pylori infection in case of dyspepsia.

  • Authors : Collin A; Lyon Sud Faculty of Medecine, Claude Bernard Lyon 1 University, Lyon, France.; Gastroenterology Department, Alpes-Léman Hospital, Contamine sur Arve, France.

Subjects: Helicobacter Infections*/Helicobacter Infections*/Helicobacter Infections*/drug therapy ; Helicobacter pylori* ; Dyspepsia*/Dyspepsia*/Dyspepsia*/diagnosis

  • Source: Helicobacter [Helicobacter] 2023 Apr; Vol. 28 (2), pp. e12952.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9605411 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis.

  • Authors : Kowada A; Advanced Research Promotion Center, Health Sciences University of Hokkaido, Ishikari-gun, Japan.; Department of Occupational Health, Kitasato University Graduate School of Medical Sciences, Kanagawa, Japan.

Subjects: Anti-Ulcer Agents*/Anti-Ulcer Agents*/Anti-Ulcer Agents*/therapeutic use ; Helicobacter Infections*/Helicobacter Infections*/Helicobacter Infections*/complications ; Helicobacter pylori*

  • Source: Helicobacter [Helicobacter] 2022 Jun; Vol. 27 (3), pp. e12886. Date of Electronic Publication: 2022 Mar 27.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9605411 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Effect of Helicobacter pylori eradication therapy on clinical and laboratory biomarkers associated with gastric damage in healthy school-aged children: A randomized non-blinded trial.

  • Authors : Lucero Y; Microbiology and Mycology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.; Department of Pediatrics and Pediatric Surgery (Northern Campus), Hospital Dr. Roberto del Río Hospital, Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Subjects: Anti-Ulcer Agents*/Anti-Ulcer Agents*/Anti-Ulcer Agents*/therapeutic use ; Helicobacter Infections*/Helicobacter Infections*/Helicobacter Infections*/diagnosis ; Helicobacter Infections*/Helicobacter Infections*/Helicobacter Infections*/drug therapy

  • Source: Helicobacter [Helicobacter] 2021 Dec; Vol. 26 (6), pp. e12853. Date of Electronic Publication: 2021 Sep 15.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9605411 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Clinical and economic impact of "triple therapy" for Helicobacter pylori eradication on peptic ulcer disease in Australia.

  • Authors : Eslick GD; The Whiteley-Martin Research Centre, Discipline of Surgery, The University of Sydney, Nepean Hospital, Penrith, NSW, Australia.; Tilden D

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/therapeutic use ; Anti-Ulcer Agents*/Anti-Ulcer Agents*/Anti-Ulcer Agents*/therapeutic use ; Helicobacter Infections*/Helicobacter Infections*/Helicobacter Infections*/drug therapy

  • Source: Helicobacter [Helicobacter] 2020 Dec; Vol. 25 (6), pp. e12751. Date of Electronic Publication: 2020 Aug 20.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9605411 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI.

  • Authors : Graham DY; Department of Medicine, Michael E. DeBakey VAMC and Baylor College of Medicine, Houston, Texas.; Lu H

Subjects: Anti-Ulcer Agents/Anti-Ulcer Agents/Anti-Ulcer Agents/*administration & dosage ; Helicobacter Infections/Helicobacter Infections/Helicobacter Infections/*drug therapy ; Helicobacter pylori/Helicobacter pylori/Helicobacter pylori/*drug effects

  • Source: Helicobacter [Helicobacter] 2019 Feb; Vol. 24 (1), pp. e12554. Date of Electronic Publication: 2018 Nov 15.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9605411 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Systematic review, meta-analysis, and meta-regression: Successful second-line treatment for Helicobacter pylori.

  • Authors : Muñoz N; Internal Medicine Department, Corporació Sanitària Universtiària ParcTauli, Sabadell, Spain.; Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Anti-Ulcer Agents/Anti-Ulcer Agents/Anti-Ulcer Agents/*therapeutic use ; Helicobacter Infections/Helicobacter Infections/Helicobacter Infections/*drug therapy

  • Source: Helicobacter [Helicobacter] 2018 Jun; Vol. 23 (3), pp. e12488. Date of Electronic Publication: 2018 Apr 16.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9605411 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies.

  • Authors : Ciccaglione AF; Departement of Medical Sciences, Section of Digestive Disease, G. d'Annunzio University, Chieti, Italy.; Cellini L

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Anti-Ulcer Agents/Anti-Ulcer Agents/Anti-Ulcer Agents/*administration & dosage ; Esomeprazole/Esomeprazole/Esomeprazole/*administration & dosage

  • Source: Helicobacter [Helicobacter] 2019 Oct; Vol. 24 (5), pp. e12606. Date of Electronic Publication: 2019 Jun 05.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9605411 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Once-daily rabeprazole, levofloxacin, clarithromycin-MR, and bismuth for Helicobacter pylori eradication: A randomized study of 7 or 14 days (ONCE study).

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Anti-Ulcer Agents/Anti-Ulcer Agents/Anti-Ulcer Agents/*administration & dosage ; Helicobacter Infections/Helicobacter Infections/Helicobacter Infections/*drug therapy

  • Source: Helicobacter [Helicobacter] 2019 Oct; Vol. 24 (5), pp. e12615. Date of Electronic Publication: 2019 Jul 07.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9605411 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  337 results for ""Helicobacter pylori""